November 23, 2024 02:10 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Third World War has begun:' Ex-Ukraine military commander-in-chief Valery Zaluzhny | UK-India Free Trade Agreement negotiations to resume in early 2024 | UK can arrest Benjamin Netanyahu if he visits country based on ICC warrant | Centre to send over 10,000 additional soldiers to violence-hit Manipur amid fresh violence | Chhattisgarh: 10 Maoists killed during encounter with security forces in Sukma
Malta-based company offers to supply 60 million doses of Sputnik V to Haryana
Sputnik V | Haryana

Malta-based company offers to supply 60 million doses of Sputnik V to Haryana

| @indiablooms | 06 Jun 2021, 12:34 am

New Delhi/IBNS: The Haryana government said it has received an "expression of Interest" from Pharma Regulatory Services Ltd, headquartered in Malta, to directly supply up to 60 million doses of Sputnik V vaccine developed by Russia at Rs 1,120 per dose.

 

The company, however, has not bid for a contract, the Haryana government added in a statement on Saturday.

"As per the offer made by the firm, the per dose cost of the vaccine will be nearly Rs 1,120. The firm has further given a timeline of 30 days to supply the first batch of 5 lakh doses, followed by 1 million doses every 20 days till supply is completed against a letter of credit issued in their name," the state government said in the statement, reported NDTV.

The Haryana Medical Services Corporation Ltd (HMSCL) floated a global tender on May 26 to buy vaccine doses from pharma companies directly, it added.

The deadline for submission of tenders was yesterday but no bids were received.

The Maltese firm only sent its expression of interest after the last date.

"Although no bid was received in the tender but an international pharma company with its headquarters in Malta namely Pharma Regulatory Services Limited has given an expression of Interest to HMSCL to provide up to 60 million doses of Sputnik V vaccine manufactured by Gamaleya Institute and Russian Direct Investment," the Haryana government said in the statement, it said.

Sputnik V is the third vaccine approved in India for use. It has recieved approval for emergency use in more than 65 countries.

It was first administered in India in Hyderabad on May 14 as part of a soft launch by Dr Reddy's Laboratories.

 

 

 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.